KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opera (OPRA) Cash & Equivalents (2017 - 2025)

Opera (OPRA) has disclosed Cash & Equivalents for 9 consecutive years, with $155.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 22.61% to $155.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $155.5 million through Dec 2025, up 22.61% year-over-year, with the annual reading at $155.5 million for FY2025, 22.61% up from the prior year.
  • Cash & Equivalents hit $155.5 million in Q4 2025 for Opera, up from $126.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $155.5 million in Q4 2025 to a low of $52.4 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $106.3 million across 5 years, with a median of $102.9 million in 2021.
  • Biggest five-year swings in Cash & Equivalents: tumbled 49.05% in 2022 and later skyrocketed 79.08% in 2023.
  • Year by year, Cash & Equivalents stood at $102.9 million in 2021, then crashed by 49.05% to $52.4 million in 2022, then surged by 79.08% to $93.9 million in 2023, then surged by 35.09% to $126.8 million in 2024, then increased by 22.61% to $155.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for OPRA at $155.5 million in Q4 2025, $126.8 million in Q4 2024, and $93.9 million in Q4 2023.